Alex Maki

Cooley advised FERMÀT, an artificial intelligence-native commerce platform generating brands’ shopping experiences for stronger engagement and conversion, on its $45 million Series B financing round.

Cooley advised Baya Systems, a leader in system intellectual property technology that empowers the acceleration of intelligent compute, on its $36 million Series B.

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.